sbynews

DelMarVa’s Premier Source for Conservative News, Opinion, Analysis, and Human Interest

Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349

The opinions expressed by columnists are their own and do not represent our advertisers

New Cancer Treatment Protocol Featuring ‘Horse Dewormer’ Ivermectin, ‘Dog Dewormer’ Fenbendazole, and Mebendazole Passes Peer Review, Marking Potential Breakthrough in Therapy

Photo by Soumyabrata NURPHOTO VIA GETTY IMAGES

A new cancer treatment protocol involving repurposed drugs Ivermectin (commonly known as a ‘horse dewormer’), Fenbendazole (a ‘dog dewormer’), and Mebendazole has recently passed peer review and is being heralded as a potential breakthrough in cancer therapy.

According to the Public Library of Science (PLOS), a research protocol is a detailed study design or set of instructions for carrying out a specific experimental process or procedure.

The hybrid orthomolecular protocol, featured in the Journal of Orthomolecular Medicine (Vol. 39.3), targets the mitochondrial-stem cell connection (MSCC), a key mechanism believed to drive cancer stem cells and tumor progression.

Dr. William Makis, a nuclear medicine physician and researcher specializing in multiple medical fields, including cancer and one of the first doctors to warn about the danger of the COVID shot, shared this news in a post on X.

More

1 thought on “New Cancer Treatment Protocol Featuring ‘Horse Dewormer’ Ivermectin, ‘Dog Dewormer’ Fenbendazole, and Mebendazole Passes Peer Review, Marking Potential Breakthrough in Therapy”

  1. I’m not convinced that this was known before but suppressed just like it’s use for COVID.
    Watch how fast the price of this medicine gets jacked-up!

Leave a Comment

Your email address will not be published. Required fields are marked *